These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 29452170)
1. Expression and significance of Sirt1 in renal allografts at the early stage of chronic renal allograft dysfunction. Xia Y; Deng J; Zhou Q; Shao X; Yang X; Sha M; Zou H Transpl Immunol; 2018 Jun; 48():18-25. PubMed ID: 29452170 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of rosiglitazone on chronic renal allograft dysfunction in rats. Deng J; Xia Y; Zhou Q; Wang X; Xiong C; Shao X; Shao M; Zou H Transpl Immunol; 2019 Jun; 54():20-28. PubMed ID: 30682409 [TBL] [Abstract][Full Text] [Related]
3. The association between activation of the ERK1/2-NF-κB signaling pathway by TIMP2 expression and chronic renal allograft dysfunction in the CRAD rat model. Chen T; Wu S; Feng L; Long S; Liu Y; Zhang C; Lu W; Shen Y; Jiang S; Chen W; Hong G; Zhou L; Wang F; Luo Y; Zou H Transpl Immunol; 2024 Feb; 82():101984. PubMed ID: 38184210 [TBL] [Abstract][Full Text] [Related]
4. Expression of the integrin-linked kinase in a rat kidney model of chronic allograft nephropathy. Han C; Zou H; Li Q; Wang Y; Shi Y; Lv T; Chen L; Zhou W Cell Biochem Biophys; 2011 Sep; 61(1):73-81. PubMed ID: 21350838 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats. Liu M; Gu M; Wu Y; Zhu P; Zhang W; Yin C; Zhang WJ J Surg Res; 2009 Nov; 157(1):e117-27. PubMed ID: 19589538 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Glycogen Synthase Kinase 3β Alleviates Chronic Renal Allograft Dysfunction in Rats. Deng J; Wang X; Zhou Q; Xia Y; Xiong C; Shao X; Zou H Transplantation; 2021 Apr; 105(4):757-767. PubMed ID: 32890133 [TBL] [Abstract][Full Text] [Related]
7. Reduction of chronic rejection of renal allografts by anti-transforming growth factor-β antibody therapy in a rat model. Guan Q; Li S; Gao S; Chen H; Nguan CY; Du C Am J Physiol Renal Physiol; 2013 Jul; 305(2):F199-207. PubMed ID: 23552866 [TBL] [Abstract][Full Text] [Related]
8. Protective effects of atorvastatin on chronic allograft nephropathy in rats. Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598 [TBL] [Abstract][Full Text] [Related]
9. Establishment of Rat Model of Insulin Resistance Exposed to Chronic Renal Allograft Dysfunction. Tang J; Cai D; Jin X; Zhang Y; Qian X; Shen R; Hu B; Jin L; Chen D Transplant Proc; 2021; 53(1):486-490. PubMed ID: 32768286 [TBL] [Abstract][Full Text] [Related]
10. [Expression of matrix metalloproteinase-9 in renal tissues of rats with chronic allograft nephropathy at early stage and the role thereof]. Zou HQ; Yao J; Wang YX; Wang J; Li D; Wang P Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):981-5. PubMed ID: 16061007 [TBL] [Abstract][Full Text] [Related]
11. CXC Chemokine Receptor Type 4 Antagonism Ameliorated Allograft Fibrosis in Rat Kidney Transplant Model. Zou XF; Gu JH; Cui ZL; Lu YW; Gu C Exp Clin Transplant; 2017 Aug; 15(4):448-452. PubMed ID: 28585910 [TBL] [Abstract][Full Text] [Related]
12. Renoprotective effects of pirfenidone on chronic renal allograft dysfunction by reducing renal interstitial fibrosis in a rat model. Qiu ZZ; He JM; Zhang HX; Yu ZH; Zhang ZW; Zhou H Life Sci; 2019 Sep; 233():116666. PubMed ID: 31325427 [TBL] [Abstract][Full Text] [Related]
13. Chronic allograft nephropathy in rats is improved by the intervention of rhein. Su J; Yin LP; Zhang X; Li BB; Liu L; Li H Transplant Proc; 2013; 45(6):2546-52. PubMed ID: 23953579 [TBL] [Abstract][Full Text] [Related]
14. Expression and Significance of RANTES and MCP-1 in Renal Tissue With Chronic Renal Allograft Dysfunction. Yan Q; Jiang H; Wang B; Sui W; Zhou H; Zou G Transplant Proc; 2016; 48(6):2034-9. PubMed ID: 27569940 [TBL] [Abstract][Full Text] [Related]
15. Urinary connective tissue growth factor increases far earlier than histopathological damage and functional deterioration in early chronic renal allograft injury. Shi Y; Tu Z; Bao J; Sun H; Wang W; Luo G; Li S; Li Y; Bu H Scand J Urol Nephrol; 2009; 43(5):390-9. PubMed ID: 19921985 [TBL] [Abstract][Full Text] [Related]
16. The Association Between Oxidative Stress Alleviation via Sulforaphane-Induced Nrf2-HO-1/NQO-1 Signaling Pathway Activation and Chronic Renal Allograft Dysfunction Improvement. Lv D; Zhou Q; Xia Y; You X; Zhao Z; Li Y; Zou H Kidney Blood Press Res; 2018; 43(1):191-205. PubMed ID: 29466800 [TBL] [Abstract][Full Text] [Related]
17. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Song E; Zou H; Yao Y; Proudfoot A; Antus B; Liu S; Jens L; Heemann U Kidney Int; 2002 Feb; 61(2):676-85. PubMed ID: 11849411 [TBL] [Abstract][Full Text] [Related]
18. Increased Expression of p-Akt correlates with Chronic Allograft Nephropathy in a Rat Kidney Model. Zhou LN; Wang N; Dong Y; Zhang Y; Zou H; Li Q; Shi Y; Chen L; Zhou W; Han C; Wang Y Cell Biochem Biophys; 2015 Apr; 71(3):1685-93. PubMed ID: 25388849 [TBL] [Abstract][Full Text] [Related]
19. Rapamycin is less fibrogenic than Cyclosporin A as demonstrated in a rat model of chronic allograft nephropathy. Luo L; Sun Z; Luo G J Surg Res; 2013 Jan; 179(1):e255-63. PubMed ID: 22480837 [TBL] [Abstract][Full Text] [Related]
20. Time course of upregulation of fibrogenic growth factors and cellular infiltration in a rodent model of chronic renal allograft rejection. Pilmore HL; Yan Y; Eris JM; Hennessy A; McCaughan GW; Bishop GA Transpl Immunol; 2002 Nov; 10(4):245-54. PubMed ID: 12507395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]